Ferrero E, Villa A, Ferrero M E, Toninelli E, Bender J R, Pardi R, Zocchi M R
Laboratory of Tumor Immunology, Scientific Institute San Raffaele, Italy.
Cancer Res. 1996 Jul 15;56(14):3211-5.
Herein we show that exposure of human umbilical vein endothelial cells to tumor necrosis factor alpha (TNFalpha) led to platelet endothelial cell adhesion molecule-1 (PECAM1) surface redistribution, disruption of cytoskeleton connections, and increased PECAM1 phosphorylation, accompanied by increased permeability to macromolecules. The in vitro use of inhibitors of tyrosine or serine-threonine kinases could prevent both PECAM1 surface redistribution and the increase in permeability induced by the cytokine. In vivo administration of lavendustin A, a natural tyrosine kinase inhibitor, protected endothelial cells from TNFalpha-dependent vascular leakage in mouse liver. We propose that the involvement of PECAM1 in TNFalpha-mediated effects on vascular permeability may depend on a dynamically regulated cytoskeletal association, related to the degree of PECAM1 phosphorylation.
在此我们表明,将人脐静脉内皮细胞暴露于肿瘤坏死因子α(TNFα)会导致血小板内皮细胞黏附分子-1(PECAM1)在细胞表面重新分布,破坏细胞骨架连接,并增加PECAM1磷酸化,同时伴随着对大分子通透性的增加。在体外使用酪氨酸或丝氨酸-苏氨酸激酶抑制剂可防止PECAM1在细胞表面重新分布以及细胞因子诱导的通透性增加。天然酪氨酸激酶抑制剂拉文达斯汀A的体内给药可保护内皮细胞免受小鼠肝脏中TNFα依赖性血管渗漏的影响。我们提出,PECAM1参与TNFα介导的对血管通透性的影响可能取决于与PECAM1磷酸化程度相关的动态调节的细胞骨架关联。